Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FN3SG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,666
Award facts
- Contract value 100% obligated
- $11,665.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (28-count unit dose packaging) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $11,665.94 and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under DLA's pharmaceutical prime vendor program, which supplies critical medications to military healthcare systems, the Defense Health Agency, and other federal medical facilities. RINVOQ (upadacitinib) is a prescription immunosuppressant used in the treatment of rheumatoid arthritis and other inflammatory conditions. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts with DLA covering a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, supporting the military's medical supply chain globally.
Quick answers
Who was awarded contract SPE2DB25FN3SG?
SPE2DB25FN3SG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FN3SG worth?
The government has obligated $11,666 on SPE2DB25FN3SG.
Is contract SPE2DB25FN3SG an order under another contract?
Yes. SPE2DB25FN3SG is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3SG competed?
The extent of competition for SPE2DB25FN3SG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award